🚨BREAKING: @ArteloBio (Nasdaq: ARTL) raised $9.475M through a private placement to launch its Solana treasury strategy, becoming the first publicly traded pharma firm to adopt $SOL as a reserve asset. Lead investor Bartosz Lipiński, ex‑Solana Labs, will advise via @cubexch, which will handle storage, staking, and DeFi execution. Artelo joins a growing list of publicly traded companies adopting SOL for treasury management.